Disclosed is the use of a benzodioxole derivative as shown in formula (I), or a pharmaceutically acceptable salt thereof and a pharmaceutical composition thereof in the treatment of diseases related to gastrointestinal motility disorders. The compound of formula (I) or the pharmaceutically acceptable salt thereof can be very efficient in the treatment of diseases related to gastrointestinal motility disorders, with low toxicity and higher medication safety.